Institutional Ownership
Pdl Biopharma Inc Com
CUSIP 69329Y104COMPDLIEURQ1 2026
13D / 13G Filings
18
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
20.8%
Max % of class reported
Institutional Holders
6
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
18 filings · latest Feb 9, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2024 | Dimensional Fund Advisors LP | 13G/A | 6.5% | 7.39M | SEC |
| 2 | Feb 10, 2023 | Dimensional Fund Advisors LP | 13G/A | 6.5% | 7.43M | SEC |
| 3 | Feb 8, 2022 | Dimensional Fund Advisors LP | 13G/A | 6.5% | 7.46M | SEC |
| 4 | Feb 12, 2021 | Dimensional Fund Advisors LP | 13G/A | 6.7% | 7.67M | SEC |
| 5 | Feb 11, 2021 | Brandes Investment Partners, LP | 13G/A | 6.2% | 7.05M | SEC |
| 6 | Feb 11, 2021 | Renaissance Technologies LLC | 13G/A | — | — | SEC |
| 7 | Jan 11, 2021 | Silver Point Capital L.P. | 13D | 20.8% | 23.78M | SEC |
| 8 | Jan 11, 2021 | Park West Asset Management LLC | 13G/A | 12.6% | 14.40M | SEC |
| 9 | Dec 16, 2020 | Silver Point Capital L.P. | 13G | 11.8% | 13.51M | SEC |
| 10 | Aug 28, 2020 | Park West Asset Management LLC | 13G/A | 5.9% | 6.72M | SEC |
8 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Pdl Biopharma Inc Com.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Diversified Trust Co | 11.6K | $27.7K |
| 2 | Rhumbline Advisers | 612 | $1.5K |
| 3 | Westside Investment Management, Inc. | 500 | $0 |
| 4 | Argent Trust Co | 41.4K | $0 |
| 5 | Financial Gravity Asset Management, Inc. | 33 | $0 |
| 6 | Murphy & Mullick Capital Management Corp | 100 | $0 |